Please wait while the formulary information is being retrieved.
ARCAPTA NEOHALER (INDACATEROL MALEATE)
- Bronchospasm prevention with COPD
- Prevention of bronchospasm with chronic bronchitis
- Prevention of bronchospasms with emphysema
75 mcg capsule with inhalation device
- Inhale the contents of one capsule (75 mcg) by inhalation route once daily
Bronchospasm prevention with COPD
- Inhale the contents of one capsule (75 mcg) by inhalation route once daily
Prevention of bronchospasm with chronic bronchitis
- Inhale the contents of one capsule (75 mcg) by inhalation route once daily
Prevention of bronchospasms with emphysema
- Inhale the contents of one capsule (75 mcg) by inhalation route once daily
- None
Contraindicated
- bromocriptine
- cabergoline
- Cafergot
- Compound 347
- Cycloset
- D.h.e.45
- dihydroergotamine
- enflurane
- ergoloid
- Ergomar
- ergotamine tartrate
- ergotamine-caffeine
- Forane
- isoflurane
- methylergonovine
- Migergot
- Migranal
- Parlodel
- sevoflurane
- Sojourn
- Terrell
- Ultane
Severe
Moderate
- None
- Acutely deteriorating asthma
Contraindicated
- Congenital long QT syndrome
- Hypokalemia
- Prolonged QT interval
Severe
Moderate
- Cardiac arrhythmia
- Chronic myocardial ischemia
- Diabetes mellitus
- Hypertension
- Seizure disorder
- Thyrotoxicosis
ARCAPTA NEOHALER (INDACATEROL MALEATE)
- Bronchospasm prevention with COPD
- Prevention of bronchospasm with chronic bronchitis
- Prevention of bronchospasms with emphysema
- Pharyngitis
- Cough
- Headache disorder
- Hypertension
More Frequent
Severe
Less Severe
- Chest pain
- Diabetes mellitus
- Sinusitis
- Cramps
- Diarrhea
- Dizziness
- Dyspnea
- Insomnia
- Muscle spasm
- Myalgias
- Nausea
- Peripheral edema
- Skin rash
- Sore throat
- Upper respiratory infection
Less Frequent
Severe
Less Severe
Rare / Very Rare
Severe
- Angina
- Asthma exacerbation
- Atrial fibrillation
- Cardiac arrhythmia
- Hyperglycemia
- Hypokalemia
- Paradoxical bronchospasm
- Pneumonia
- Tachycardia
Less Severe
- Dyspepsia
- Palpitations
- Pruritus of skin
Contraindicated
None
Severe Precaution
Indacaterol
No safety and efficacy established. Not indicated for asthma.
- 1 Day – 18 Years
- No safety and efficacy established. Not indicated for asthma.
Management or Monitoring Precaution
None
Indacaterol
- Severity Level:
C
- Additional Notes: Insufficient human data available
Contraindicated
None
| General | Excretion Potential | Effect on Infant | Notes |
| None |
Precaution Exists
Indacaterol
Insufficient human data, excreted in rats
| General | Excretion Potential | Effect on Infant | Notes |
| Evaluate use carefully | Unknown | Not known; no or inclusive data | Insufficient human data, excreted in rats |
No Known Risk
None
| General | Excretion Potential | Effect on Infant | Notes |
| None |
Contraindicated
None
Precaution Exists
None
No Known Risk
None
- Rarely, serious (sometimes fatal) breathing problems have happened to people with asthma using a long-acting inhaled beta agonist (salmeterol). Since indacaterol is similar to salmeterol, it might cause these serious breathing problems. Indacaterol has not been shown to be safe or effective to treat asthma and is not approved for this use. Talk with your doctor about the risks and benefits of treatment with this medication.
| Bronchospasm prevention with COPD | |
| J44 | Other chronic obstructive pulmonary disease |
| J44.9 | Chronic obstructive pulmonary disease, unspecified |
| Prevention of bronchospasm with chronic bronchitis | |
| J41 | Simple and mucopurulent chronic bronchitis |
| J41.0 | Simple chronic bronchitis |
| J41.1 | Mucopurulent chronic bronchitis |
| J41.8 | Mixed simple and mucopurulent chronic bronchitis |
| J42 | Unspecified chronic bronchitis |
| J44 | Other chronic obstructive pulmonary disease |
| J44.9 | Chronic obstructive pulmonary disease, unspecified |
| Prevention of bronchospasms with emphysema | |
| J43 | Emphysema |
| J43.0 | Unilateral pulmonary emphysema [macleod's syndrome] |
| J43.1 | Panlobular emphysema |
| J43.2 | Centrilobular emphysema |
| J43.8 | Other emphysema |
| J43.9 | Emphysema, unspecified |
| J44 | Other chronic obstructive pulmonary disease |
| J44.9 | Chronic obstructive pulmonary disease, unspecified |
| 0-9 | A-Z |
|---|---|
| J41 | Simple and mucopurulent chronic bronchitis |
| J41.0 | Simple chronic bronchitis |
| J41.1 | Mucopurulent chronic bronchitis |
| J41.8 | Mixed simple and mucopurulent chronic bronchitis |
| J42 | Unspecified chronic bronchitis |
| J43 | Emphysema |
| J43.0 | Unilateral pulmonary emphysema [macleod's syndrome] |
| J43.1 | Panlobular emphysema |
| J43.2 | Centrilobular emphysema |
| J43.8 | Other emphysema |
| J43.9 | Emphysema, unspecified |
| J44 | Other chronic obstructive pulmonary disease |
| J44 | Other chronic obstructive pulmonary disease |
| J44 | Other chronic obstructive pulmonary disease |
| J44.9 | Chronic obstructive pulmonary disease, unspecified |
| J44.9 | Chronic obstructive pulmonary disease, unspecified |
| J44.9 | Chronic obstructive pulmonary disease, unspecified |
Formulary Reference Tool